SlideShare a Scribd company logo
1 of 21
GENKOMAX SCIENCES PVT.LTD
THAYOFLO
12.5,25,50,62.5,75,88,100,125,150 mcg Thyroxine Tabs
About Thyroxine
 Thyroxine is the primary hormone which is
secreted by the thyroid gland. Thyroxine
plays an important role in controlling body
metabolism and regulates the functions of
the heart and the digestive tract. It also
keeps the bones strong, helps in
development of the brain and controls
muscle growth.
Hypothyroidism occurs when your body doesn’t
produce enough thyroid hormones. The thyroid
is a small, butterfly-shaped gland that sits at the
front of your neck. It releases hormones to help
your body regulate and use energy. It is also
related to autoimmune disease known as
Hashimoto’s diseases. Autoimmune disease is
when the body begins attacking itself, which
results in the destruction of tissue.
What is hypothyroidism?
Signs and symptoms of
hypothyroidism.
1- Fatigue
2-Depression
3-Constipation
4-Dry skin
5-Weight gain
6-Muscle weakness
7-Pain and stiffness in your joints
Pharmacodynamic Properties
Levothyroxine (T4) is a naturally occurring hormone produced
by the thyroid gland and converted to the more active
hormone triiodothyronine (T3) in peripheral tissues. The
thyroid hormones are required for normal growth and
development, particularly of the nervous system. They
increase the resting or basal metabolic rate of the whole
organism and have stimulatory effects on the heart, skeletal
muscle, liver and kidney. Thyroid hormones enhance lipolysis
and the utilization of carbohydrate.
Mode of action
Levothyroxine (T4) is a synthetic form of thyroxine, which is
converted to active metabolite L-triiodothyronine (T3). T3
and T4 bind to thyroid receptor proteins & exert metabolic
effects through control of DNA transcription and protein
synthesis. It promotes gluconeogenesis, increases utilization
and mobilization of glycogen stores, stimulates protein
synthesis, and increases basal metabolic rate.
 Pharmacokinetic Properties
Absorption and Distribution:-
Following oral administration the absorption of
levothyroxine is incomplete and variable especially
when taken with food. The amount absorbed increases
during fasting conditions. Levothyroxine is nearly totally
bound to serum protein.
 Metabolism and Elimination:-
The main pathway for the metabolism of levothyroxine (T4) is its
conversion, by deiodination, to the active metabolite
triiodothyronine (T3). Further deiodination of T4 and T3 leads to
production of inactive products.
Levothyroxine is eliminated slowly from the body with a half-life of
approximately 7 days in a normal person. This may be reduced in
hyperthyroid states or increased in hypothyroid patients. Renal or
hepatic disease do not appear to have any significant effect on the
disposition of levothyroxine. In man approximately 20-40% of
levothyroxine is eliminated in the faeces and approximately 30-
55% of a dose of levothyroxine is excreted in the urine.
 Dosage and Administration
If the dose of thyroxine is increased too rapidly, symptoms
such as diarrhoea, nervousness, rapid pulse, insomnia,
tremors and sometimes angina pain where there is latent
myocardial ischaemia may occur, and the dosage must be
reduced or withheld for a day or two, then restarted at a
lower level. Thayoflo tablets should be swallowed whole,
and taken with a full glass of water. Thayoflo tablets should
not be split. Thyroxine tablets should preferably be taken
on an empty stomach. Missed dosage – If a scheduled
daily dose is missed, the dose should be taken as soon as
the patient remembers, unless it is almost time for the
patient’s next dose. Two doses should not be taken
together.
Use in adults:-
Initially 50 to 100 micrograms daily and adjusted at four
or six week intervals by 50 micrograms until attainment
of clinical and biochemical euthyroidism. This may
require doses of 100 to 150 micrograms daily. With
patients aged over 50 years, it is not advisable to exceed
50 micrograms a day initially. Where there is cardiac
disease 25 micrograms, given as 50 micrograms on
alternate days, is more suitable. In this condition the
daily dosage may be slowly increased by 25 micrograms
increments (given as 50 micrograms on alternate days)
at intervals of perhaps four weeks.
Use in children:-
In congenital hypothyroidism and juvenile myxoedema, the largest
dose consistent with freedom from toxic effects should be given. The
dosage is guided by clinical response, growth assessment and
appropriate thyroid function tests - clinically normal pulse rate and
absence of diarrhoea or constipation are the most useful indicators.
Thyrotrophin levels may remain elevated during the first year of life in
children with neonatal hypothyroidism due to resetting of the
hypothalamic-pituitary axis.
For infants with congenital hypothyroidism a suitable starting dose is
25 micrograms levothyroxine sodium given as 50 micrograms every
other day is advisable. This may be slowly increased by increments of
25 micrograms (given as 50 micrograms on alternate days) every two
to four weeks until optimal response is achieved.
Warning and precautions:-
Thyroxine has a narrow therapeutic index. Appropriate
thyroxine dosage is based upon clinical assessment and
laboratory monitoring of thyroid function tests. During the
initial titration period, careful dosage titration and monitoring
is necessary to avoid the consequences of under- or over-
treatment.
Treatment with thyroxine in patients with panhypopituitarism
or other causes predisposing to adrenal insufficiency may
cause reactions including dizziness, weakness, malaise, weight
loss, hypotension and adrenal crisis. It is advisable to initiate
corticosteroid therapy before giving levothyroxine sodium in
these cases.
Use during Pregnancy and Lactation:-
Levothyroxine has been taken by a large number of pregnant
women and women of childbearing age without any form of
definite disturbances in the reproductive process having been
observed so far. Thyroid hypo- or hyperactivity in the mother
may, however, unfavourably influence the fetal outcome or
well-being.
Lactation:-
Levothyroxine is excreted in breast milk in low concentrations
and this may be sufficient to interfere with neonatal screening
for hypothroidism.
How is this thayoflo best taken
Use this medicine Thayoflo as ordered by your doctor. Read all information given to
you. Follow all instructions closely.
1) Take on an empty stomach 30 minutes before breakfast.
2) Do not take iron products, antacids that have aluminum or magnesium, or calcium
carbonate, within 4 hours before or 4 hours after taking this medicine.
3) If you drink grapefruit juice or eat grapefruit often, talk with your doctor.
4) To gain the most benefit, do not miss doses.
5) Some other drugs may need to be taken at some other time than this medicine
(levothyroxine tablets). If you take other drugs, check with your doctor or pharmacist
to see if you need to take them.
 Adverse Effects:-
The following effects are indicative of excessive dosage and
usually disappear on reduction of dosage or withdrawal of
treatment for a few days.
1)Immune system disorders:-Hypersensitivity reactions
such as skin rash and pruritis.
2)Metabolism and nutrition disorders:- Increased appetite,
abdominal cramps, nausea, vomiting and diarrhoea.
3)Nervous system disorders:-Excitability, insomnia,
restlessness, headache, seizure, and psychotic depression.
4) Cardiac disorders:-Anginal pain, cardiac arrhythmias,
palpitations, tachycardia, increased blood pressure, heart
failure, myocardial infarction.
5) Respiratory disorders:- Dyspnea (shortness of breath)
6)Skin and subcutaneous tissue disorders:-Sweating, flushing,
hair loss.
 Overdose
Symptoms
In addition to exaggeration of side effects the following
symptoms may be seen: Agitation, confusion, irritability,
hyperactivity, headache, sweating, mydriasis, tachycardia,
arrhythmias, and increased bowel movements .
END OF SLIDE

More Related Content

What's hot

What's hot (20)

Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
calcium channel blockers
calcium channel blockerscalcium channel blockers
calcium channel blockers
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
 
NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 
thiazides
 thiazides  thiazides
thiazides
 
Metformin A Pharmacological Preespective
Metformin A Pharmacological PreespectiveMetformin A Pharmacological Preespective
Metformin A Pharmacological Preespective
 
Heparin
HeparinHeparin
Heparin
 
Antihypertensive drugs naser
Antihypertensive drugs naserAntihypertensive drugs naser
Antihypertensive drugs naser
 
Antiemetic's _ Ondansetron
Antiemetic's  _ OndansetronAntiemetic's  _ Ondansetron
Antiemetic's _ Ondansetron
 
Theophyllin in Asthma Patient
Theophyllin in Asthma PatientTheophyllin in Asthma Patient
Theophyllin in Asthma Patient
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
 
Insulin
InsulinInsulin
Insulin
 
Digoxin
DigoxinDigoxin
Digoxin
 
Atorvastatin
AtorvastatinAtorvastatin
Atorvastatin
 
Thyroid gland
Thyroid glandThyroid gland
Thyroid gland
 
Estrogen
EstrogenEstrogen
Estrogen
 
Phenytoin
PhenytoinPhenytoin
Phenytoin
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 

Similar to Presentation..thyroxine

Thyroid gland - disordesa , symptomes and treatment
Thyroid gland - disordesa , symptomes and treatment Thyroid gland - disordesa , symptomes and treatment
Thyroid gland - disordesa , symptomes and treatment Areej Abu Hanieh
 
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.Taj Pharma
 
Hypothyroidism pathology presentation2
Hypothyroidism pathology presentation2Hypothyroidism pathology presentation2
Hypothyroidism pathology presentation2Jordan Squires
 
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptx
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptxCOMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptx
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptxLalaAhmbot
 
Liothyronine Sodium Tablets (Thyro3)
Liothyronine Sodium Tablets (Thyro3)Liothyronine Sodium Tablets (Thyro3)
Liothyronine Sodium Tablets (Thyro3)Clearsky Pharmacy
 
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptx
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptxTHYROID AND ANTITHYROID DRUGS PRESENTATION.pptx
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptxJhansi Uppu
 
Diagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxDiagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxvivianOkoli1
 
GOITER (DISEASE OF THYRIOD GLAND)
GOITER (DISEASE OF THYRIOD GLAND)GOITER (DISEASE OF THYRIOD GLAND)
GOITER (DISEASE OF THYRIOD GLAND)Nasir Yahaya
 
Thyroid hormones and thyroid inhibitors drdhriti
Thyroid hormones and thyroid inhibitors   drdhritiThyroid hormones and thyroid inhibitors   drdhriti
Thyroid hormones and thyroid inhibitors drdhritihttp://neigrihms.gov.in/
 
Drugs for thyroid and parathyroid disorders
Drugs for thyroid and parathyroid disordersDrugs for thyroid and parathyroid disorders
Drugs for thyroid and parathyroid disordersDr. Marya Ahsan
 
Thyroid Drugs2[1]
Thyroid Drugs2[1]Thyroid Drugs2[1]
Thyroid Drugs2[1]girlie
 
HYPOTHYROIDISM IN PREGNACY: COMMON DILEMMAS, Dr. Jyoti Bhaskar
HYPOTHYROIDISM IN PREGNACY:COMMON DILEMMAS, Dr. Jyoti Bhaskar HYPOTHYROIDISM IN PREGNACY:COMMON DILEMMAS, Dr. Jyoti Bhaskar
HYPOTHYROIDISM IN PREGNACY: COMMON DILEMMAS, Dr. Jyoti Bhaskar Lifecare Centre
 
Hypothyroidism Diagnosis, Etiopathogenesis and Treatment
Hypothyroidism Diagnosis, Etiopathogenesis and TreatmentHypothyroidism Diagnosis, Etiopathogenesis and Treatment
Hypothyroidism Diagnosis, Etiopathogenesis and TreatmentPranatiChavan
 
Thyroid & Antithyroid drugs Nursing (1).ppt
Thyroid & Antithyroid drugs Nursing (1).pptThyroid & Antithyroid drugs Nursing (1).ppt
Thyroid & Antithyroid drugs Nursing (1).pptwajidullah9551
 
Mx Thyroid Disorders. .ppt
Mx Thyroid Disorders.               .pptMx Thyroid Disorders.               .ppt
Mx Thyroid Disorders. .ppttarakeeshbai1802
 

Similar to Presentation..thyroxine (20)

Thyroid gland - disordesa , symptomes and treatment
Thyroid gland - disordesa , symptomes and treatment Thyroid gland - disordesa , symptomes and treatment
Thyroid gland - disordesa , symptomes and treatment
 
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.
Levothyroxine 50mcg and 100mcg tablets pil, taj pharmaceuticals.
 
Hypothyroidism pathology presentation2
Hypothyroidism pathology presentation2Hypothyroidism pathology presentation2
Hypothyroidism pathology presentation2
 
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptx
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptxCOMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptx
COMPILED-POWERPOINT-GROUP-01-Peptide-Hormones-and-the-Endocrine-System.pptx
 
Liothyronine Sodium Tablets (Thyro3)
Liothyronine Sodium Tablets (Thyro3)Liothyronine Sodium Tablets (Thyro3)
Liothyronine Sodium Tablets (Thyro3)
 
‫Thyroid gland disorders
‫Thyroid gland disorders‫Thyroid gland disorders
‫Thyroid gland disorders
 
Thyroid disorders
Thyroid disorders Thyroid disorders
Thyroid disorders
 
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptx
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptxTHYROID AND ANTITHYROID DRUGS PRESENTATION.pptx
THYROID AND ANTITHYROID DRUGS PRESENTATION.pptx
 
Diagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptxDiagnosis and treatment of hypothyroidism.pptx
Diagnosis and treatment of hypothyroidism.pptx
 
Thyronorm Tablets
Thyronorm TabletsThyronorm Tablets
Thyronorm Tablets
 
Goiter
GoiterGoiter
Goiter
 
GOITER (DISEASE OF THYRIOD GLAND)
GOITER (DISEASE OF THYRIOD GLAND)GOITER (DISEASE OF THYRIOD GLAND)
GOITER (DISEASE OF THYRIOD GLAND)
 
Thyroid hormones and thyroid inhibitors drdhriti
Thyroid hormones and thyroid inhibitors   drdhritiThyroid hormones and thyroid inhibitors   drdhriti
Thyroid hormones and thyroid inhibitors drdhriti
 
Drugs for thyroid and parathyroid disorders
Drugs for thyroid and parathyroid disordersDrugs for thyroid and parathyroid disorders
Drugs for thyroid and parathyroid disorders
 
Thyroid Drugs2[1]
Thyroid Drugs2[1]Thyroid Drugs2[1]
Thyroid Drugs2[1]
 
HYPOTHYROIDISM IN PREGNACY: COMMON DILEMMAS, Dr. Jyoti Bhaskar
HYPOTHYROIDISM IN PREGNACY:COMMON DILEMMAS, Dr. Jyoti Bhaskar HYPOTHYROIDISM IN PREGNACY:COMMON DILEMMAS, Dr. Jyoti Bhaskar
HYPOTHYROIDISM IN PREGNACY: COMMON DILEMMAS, Dr. Jyoti Bhaskar
 
Hypothyroidism Diagnosis, Etiopathogenesis and Treatment
Hypothyroidism Diagnosis, Etiopathogenesis and TreatmentHypothyroidism Diagnosis, Etiopathogenesis and Treatment
Hypothyroidism Diagnosis, Etiopathogenesis and Treatment
 
Drugs Used in Endocrine Alteration
Drugs Used in Endocrine AlterationDrugs Used in Endocrine Alteration
Drugs Used in Endocrine Alteration
 
Thyroid & Antithyroid drugs Nursing (1).ppt
Thyroid & Antithyroid drugs Nursing (1).pptThyroid & Antithyroid drugs Nursing (1).ppt
Thyroid & Antithyroid drugs Nursing (1).ppt
 
Mx Thyroid Disorders. .ppt
Mx Thyroid Disorders.               .pptMx Thyroid Disorders.               .ppt
Mx Thyroid Disorders. .ppt
 

Recently uploaded

Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 

Recently uploaded (20)

Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 

Presentation..thyroxine

  • 2.
  • 3. About Thyroxine  Thyroxine is the primary hormone which is secreted by the thyroid gland. Thyroxine plays an important role in controlling body metabolism and regulates the functions of the heart and the digestive tract. It also keeps the bones strong, helps in development of the brain and controls muscle growth.
  • 4.
  • 5. Hypothyroidism occurs when your body doesn’t produce enough thyroid hormones. The thyroid is a small, butterfly-shaped gland that sits at the front of your neck. It releases hormones to help your body regulate and use energy. It is also related to autoimmune disease known as Hashimoto’s diseases. Autoimmune disease is when the body begins attacking itself, which results in the destruction of tissue. What is hypothyroidism?
  • 6. Signs and symptoms of hypothyroidism. 1- Fatigue 2-Depression 3-Constipation 4-Dry skin 5-Weight gain 6-Muscle weakness 7-Pain and stiffness in your joints
  • 7. Pharmacodynamic Properties Levothyroxine (T4) is a naturally occurring hormone produced by the thyroid gland and converted to the more active hormone triiodothyronine (T3) in peripheral tissues. The thyroid hormones are required for normal growth and development, particularly of the nervous system. They increase the resting or basal metabolic rate of the whole organism and have stimulatory effects on the heart, skeletal muscle, liver and kidney. Thyroid hormones enhance lipolysis and the utilization of carbohydrate.
  • 8.
  • 9. Mode of action Levothyroxine (T4) is a synthetic form of thyroxine, which is converted to active metabolite L-triiodothyronine (T3). T3 and T4 bind to thyroid receptor proteins & exert metabolic effects through control of DNA transcription and protein synthesis. It promotes gluconeogenesis, increases utilization and mobilization of glycogen stores, stimulates protein synthesis, and increases basal metabolic rate.
  • 10.  Pharmacokinetic Properties Absorption and Distribution:- Following oral administration the absorption of levothyroxine is incomplete and variable especially when taken with food. The amount absorbed increases during fasting conditions. Levothyroxine is nearly totally bound to serum protein.
  • 11.  Metabolism and Elimination:- The main pathway for the metabolism of levothyroxine (T4) is its conversion, by deiodination, to the active metabolite triiodothyronine (T3). Further deiodination of T4 and T3 leads to production of inactive products. Levothyroxine is eliminated slowly from the body with a half-life of approximately 7 days in a normal person. This may be reduced in hyperthyroid states or increased in hypothyroid patients. Renal or hepatic disease do not appear to have any significant effect on the disposition of levothyroxine. In man approximately 20-40% of levothyroxine is eliminated in the faeces and approximately 30- 55% of a dose of levothyroxine is excreted in the urine.
  • 12.  Dosage and Administration If the dose of thyroxine is increased too rapidly, symptoms such as diarrhoea, nervousness, rapid pulse, insomnia, tremors and sometimes angina pain where there is latent myocardial ischaemia may occur, and the dosage must be reduced or withheld for a day or two, then restarted at a lower level. Thayoflo tablets should be swallowed whole, and taken with a full glass of water. Thayoflo tablets should not be split. Thyroxine tablets should preferably be taken on an empty stomach. Missed dosage – If a scheduled daily dose is missed, the dose should be taken as soon as the patient remembers, unless it is almost time for the patient’s next dose. Two doses should not be taken together.
  • 13. Use in adults:- Initially 50 to 100 micrograms daily and adjusted at four or six week intervals by 50 micrograms until attainment of clinical and biochemical euthyroidism. This may require doses of 100 to 150 micrograms daily. With patients aged over 50 years, it is not advisable to exceed 50 micrograms a day initially. Where there is cardiac disease 25 micrograms, given as 50 micrograms on alternate days, is more suitable. In this condition the daily dosage may be slowly increased by 25 micrograms increments (given as 50 micrograms on alternate days) at intervals of perhaps four weeks.
  • 14. Use in children:- In congenital hypothyroidism and juvenile myxoedema, the largest dose consistent with freedom from toxic effects should be given. The dosage is guided by clinical response, growth assessment and appropriate thyroid function tests - clinically normal pulse rate and absence of diarrhoea or constipation are the most useful indicators. Thyrotrophin levels may remain elevated during the first year of life in children with neonatal hypothyroidism due to resetting of the hypothalamic-pituitary axis. For infants with congenital hypothyroidism a suitable starting dose is 25 micrograms levothyroxine sodium given as 50 micrograms every other day is advisable. This may be slowly increased by increments of 25 micrograms (given as 50 micrograms on alternate days) every two to four weeks until optimal response is achieved.
  • 15. Warning and precautions:- Thyroxine has a narrow therapeutic index. Appropriate thyroxine dosage is based upon clinical assessment and laboratory monitoring of thyroid function tests. During the initial titration period, careful dosage titration and monitoring is necessary to avoid the consequences of under- or over- treatment. Treatment with thyroxine in patients with panhypopituitarism or other causes predisposing to adrenal insufficiency may cause reactions including dizziness, weakness, malaise, weight loss, hypotension and adrenal crisis. It is advisable to initiate corticosteroid therapy before giving levothyroxine sodium in these cases.
  • 16. Use during Pregnancy and Lactation:- Levothyroxine has been taken by a large number of pregnant women and women of childbearing age without any form of definite disturbances in the reproductive process having been observed so far. Thyroid hypo- or hyperactivity in the mother may, however, unfavourably influence the fetal outcome or well-being. Lactation:- Levothyroxine is excreted in breast milk in low concentrations and this may be sufficient to interfere with neonatal screening for hypothroidism.
  • 17. How is this thayoflo best taken Use this medicine Thayoflo as ordered by your doctor. Read all information given to you. Follow all instructions closely. 1) Take on an empty stomach 30 minutes before breakfast. 2) Do not take iron products, antacids that have aluminum or magnesium, or calcium carbonate, within 4 hours before or 4 hours after taking this medicine. 3) If you drink grapefruit juice or eat grapefruit often, talk with your doctor. 4) To gain the most benefit, do not miss doses. 5) Some other drugs may need to be taken at some other time than this medicine (levothyroxine tablets). If you take other drugs, check with your doctor or pharmacist to see if you need to take them.
  • 18.  Adverse Effects:- The following effects are indicative of excessive dosage and usually disappear on reduction of dosage or withdrawal of treatment for a few days. 1)Immune system disorders:-Hypersensitivity reactions such as skin rash and pruritis. 2)Metabolism and nutrition disorders:- Increased appetite, abdominal cramps, nausea, vomiting and diarrhoea.
  • 19. 3)Nervous system disorders:-Excitability, insomnia, restlessness, headache, seizure, and psychotic depression. 4) Cardiac disorders:-Anginal pain, cardiac arrhythmias, palpitations, tachycardia, increased blood pressure, heart failure, myocardial infarction. 5) Respiratory disorders:- Dyspnea (shortness of breath) 6)Skin and subcutaneous tissue disorders:-Sweating, flushing, hair loss.
  • 20.  Overdose Symptoms In addition to exaggeration of side effects the following symptoms may be seen: Agitation, confusion, irritability, hyperactivity, headache, sweating, mydriasis, tachycardia, arrhythmias, and increased bowel movements .